Taliglucerase Alfa
CAS 37228-64-1 2 FDA-DMF suppliersBiologic
Overview
Taliglucerase Alfa is a plant cell-expressed recombinant enzyme used for enzyme replacement therapy in patients with Type 1 Gaucher disease. It works by replacing the defective enzyme glucocerebrosidase, helping to break down fatty substances that can build up in cells and organs.
Therapeutic areas
Genetic DisordersMetabolic Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.